Overview

Quercetin in Coronary Artery By-pass Surgery

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the anti-inflammatory and anti-senescence effects of quercetin during coronary artery by-pass graft surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Montreal Heart Institute
Treatments:
Quercetin